2hz9 Citations

Spackling the crack: stabilizing human fibroblast growth factor-1 by targeting the N and C terminus beta-strand interactions.

J Mol Biol 371 256-68 (2007)
Related entries: 2hw9, 2hwa, 2hwm, 2ntd

Cited: 22 times
EuropePMC logo PMID: 17570396

Abstract

The beta-trefoil protein human fibroblast growth factor-1 (FGF-1) is made up of a six-stranded antiparallel beta-barrel closed off on one end by three beta-hairpins, thus exhibiting a 3-fold axis of structural symmetry. The N and C terminus beta-strands hydrogen bond to each other and their interaction is postulated from both NMR and X-ray structure data to be important in folding and stability. Specific mutations within the adjacent N and C terminus beta-strands of FGF-1 are shown to provide a substantial increase in stability. This increase is largely correlated with an increased folding rate constant, and with a smaller but significant decrease in the unfolding rate constant. A series of stabilizing mutations are subsequently combined and result in a doubling of the DeltaG value of unfolding. When taken in the context of previous studies of stabilizing mutations, the results indicate that although FGF-1 is known for generally poor thermal stability, the beta-trefoil architecture appears capable of substantial thermal stability. Targeting stabilizing mutations within the N and C terminus beta-strand interactions of a beta-barrel architecture may be a generally useful approach to increase protein stability. Such stabilized mutations of FGF-1 are shown to exhibit significant increases in effective mitogenic potency, and may prove useful as "second generation" forms of FGF-1 for application in angiogenic therapy.

Reviews - 2hz9 mentioned but not cited (1)

  1. FGF1 - a new weapon to control type 2 diabetes mellitus. Gasser E, Moutos CP, Downes M, Evans RM. Nat Rev Endocrinol 13 599-609 (2017)


Reviews citing this publication (5)

  1. The FGF family: biology, pathophysiology and therapy. Beenken A, Mohammadi M. Nat Rev Drug Discov 8 235-253 (2009)
  2. Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair. Jay SM, Lee RT. Circ Res 113 933-943 (2013)
  3. Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles. Alsenaidy MA, Jain NK, Kim JH, Middaugh CR, Volkin DB. Front Pharmacol 5 39 (2014)
  4. Using the folding landscapes of proteins to understand protein function. Giri Rao VV, Gosavi S. Curr Opin Struct Biol 36 67-74 (2016)
  5. Structural interactomics: informatics approaches to aid the interpretation of genetic variation and the development of novel therapeutics. Lee S, Brown A, Pitt WR, Higueruelo AP, Gong S, Bickerton GR, Schreyer A, Tanramluk D, Baylay A, Blundell TL. Mol Biosyst 5 1456-1472 (2009)

Articles citing this publication (16)

  1. Extracting function from a beta-trefoil folding motif. Gosavi S, Whitford PC, Jennings PA, Onuchic JN. Proc Natl Acad Sci U S A 105 10384-10389 (2008)
  2. Experimental support for the evolution of symmetric protein architecture from a simple peptide motif. Lee J, Blaber M. Proc Natl Acad Sci U S A 108 126-130 (2011)
  3. A polypeptide "building block" for the β-trefoil fold identified by "top-down symmetric deconstruction". Lee J, Blaber SI, Dubey VK, Blaber M. J Mol Biol 407 744-763 (2011)
  4. Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility. Shukla H, Shukla R, Sonkar A, Pandey T, Tripathi T. Sci Rep 7 1058 (2017)
  5. Computer-assisted engineering of hyperstable fibroblast growth factor 2. Dvorak P, Bednar D, Vanacek P, Balek L, Eiselleova L, Stepankova V, Sebestova E, Kunova Bosakova M, Konecna Z, Mazurenko S, Kunka A, Vanova T, Zoufalova K, Chaloupkova R, Brezovsky J, Krejci P, Prokop Z, Dvorak P, Damborsky J. Biotechnol Bioeng 115 850-862 (2018)
  6. The interaction between thermodynamic stability and buried free cysteines in regulating the functional half-life of fibroblast growth factor-1. Lee J, Blaber M. J Mol Biol 393 113-127 (2009)
  7. Accelerated healing in NONcNZO10/LtJ type 2 diabetic mice by FGF-1. Blaber SI, Diaz J, Blaber M. Wound Repair Regen 23 538-549 (2015)
  8. Experimental support for the foldability-function tradeoff hypothesis: segregation of the folding nucleus and functional regions in fibroblast growth factor-1. Longo L, Lee J, Blaber M. Protein Sci 21 1911-1920 (2012)
  9. A logical OR redundancy within the Asx-Pro-Asx-Gly type I beta-turn motif. Lee J, Dubey VK, Longo LM, Blaber M. J Mol Biol 377 1251-1264 (2008)
  10. An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1. Alsenaidy MA, Wang T, Kim JH, Joshi SB, Lee J, Blaber M, Volkin DB, Middaugh CR. Protein Sci 21 418-432 (2012)
  11. Structural basis of conserved cysteine in the fibroblast growth factor family: evidence for a vestigial half-cystine. Lee J, Blaber M. J Mol Biol 393 128-139 (2009)
  12. Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application. Xia X, Babcock JP, Blaber SI, Harper KM, Blaber M. PLoS One 7 e48210 (2012)
  13. Effect of extension of the heparin binding pocket on the structure, stability, and cell proliferation activity of the human acidic fibroblast growth factor. Davis JE, Gundampati RK, Jayanthi S, Anderson J, Pickhardt A, Koppolu BP, Zaharoff DA, Kumar TKS. Biochem Biophys Rep 13 45-57 (2018)
  14. In vitro refolding of triosephosphate isomerase from L. donovani. Kumar K, Bhargava P, Roy U. Appl Biochem Biotechnol 164 1207-1214 (2011)
  15. Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor. Davis JE, Alghanmi A, Gundampati RK, Jayanthi S, Fields E, Armstrong M, Weidling V, Shah V, Agrawal S, Koppolu BP, Zaharoff DA, Kumar TKS. Arch Biochem Biophys 654 115-125 (2018)
  16. Biologically active fibroblast growth factor 1 tagged with various epitopes. Asada M, Honda E, Imamura T. BMC Res Notes 1 42 (2008)